Have some news you want to share with the Oregon Bio community? Fill out our submission form.
Bozinovic comes from Biocom Institute to join the local bio organization as it turns 30
(Portland, Ore.) –The Oregon Bioscience Association’s Board of Directors announced today the selection of its new Executive Director, Liisa Bozinovic, who will assume leadership of the trade/industry association on April 11, 2019.
Bozinovic comes to Oregon’s growing life science and medical device industry organization from its peer organization, Biocom, where she currently […]
Eugene-based NemaMetrix, a biotech company that developed DNA testing equipment using nematode worms, has raised another $5 million, according to a filing with the U.S. Securities and Exchange Commission.
Oregon Venture Fund was the lead investor and Rogue Venture Partners also participated, […]
AbSci and Sanofi entered into a collaboration to improve the manufacturability for two of Sanofi’s biotherapeutics
VANCOUVER, Wash., Jan. 9, 2019 /PRNewswire/
AbSci, a global leader in biotherapeutic discovery and manufacturing technologies, today announced a collaboration with Sanofi. Under the terms of the agreement, AbSci will apply its breakthrough E.coli manufacturing platform, SoluProTM, and its novel optimization assay system, to two of Sanofi’s biotherapeutic molecules. AbSci’s proprietary technology platform is designed with the ability […]
Veana Therapeutics is pleased to announce a Phase I Small Business Innovation Research (SBIR) grant award from the NIH National Cancer Institute to conduct proof-of-concept pre-clinical studies of its lead product, VIMO (Veana Immune Modulator) in combination with immune checkpoint inhibitors in triple negative breast cancer. Learn more about Veana here.
By Denise Szott – Contributing writer for Portland Business Journal
The Portland company developed a drug to cure malaria that is easy and cheap to manufacture